Growing evidence has revealed that loss of SHP-1 leads to constitutive activation of STAT3 in hematologic malignancies, since ectopic expression of SHP-1 in leukemia cells substantially decreases the levels of activated STAT3 [40]. This evidence concerns the gene STAT3 and leukemia.